CDC Article-US Medical Eligibility Criteria for Contraceptive Use, 2010

32 MMWR June 18, 2010
509. Joshi JV, Joshi UM, Sankholi GM, et al. A study of interaction of lowdose
combination oral contraceptive with ampicillin and metronidazole.
Contraception 1980;22:643–52.
510. Kakouris H, Kovacs GT. Pill failure and nonuse of secondary precautions.
Br J Fam Plann 1992;18:41–4.
511. Kakouris H, Kovacs GT. How common are predisposing factors to pill
failure among pill users? Br J Fam Plann 1994;20:33–5.
512. Kovacs GT, Riddoch G, Duncombe P, et al. Inadvertent pregnancies
in oral contraceptive users. Med J Aust 1989;150:549–51.
513. Lequeux A. Pregnancy under oral contraceptives after treatment with
tetracycline] [in French]. Louv Med 1980;99:413–4.
514. London BM, Lookingbill DP. Frequency of pregnancy in acne
patients taking oral antibiotics and oral contraceptives. Arch Dermatol
1994;130:392–3.
515. Maggiolo F, Puricelli G, Dottorini M, et al. The effects of ciprofloxacin
on oral contraceptive steroid treatments. Drugs Exp Clin Res
1991;17:451–4.
516. Murphy AA, Zacur HA, Charache P, Burkman RT. The effect of
tetracycline on levels of oral contraceptives. Am J Obstet Gynecol
1991;164:28–33.
517. Neely JL, Abate M, Swinker M, D’Angio R. The effect of doxycycline
on serum levels of ethinyl estradiol, noretindrone, and endogenous
progesterone. Obstet Gynecol 1991;77:416–20.
518. Pillans PI, Sparrow MJ. Pregnancy associated with a combined oral contraceptive
and itraconazole [comment]. N Z Med J 1993;106:436.
519. Scholten PC, Droppert RM, Zwinkels MG, et al. No interaction
between ciprofloxacin and an oral contraceptive. Antimicrob Agents
Chemother 1998;42:3266–8.
520. Silber TJ. Apparent oral contraceptive failure associated with antibiotic
administration. J Adolesc Health Care 1983;4:287–9.
521. Sparrow MJ. Pill method failures. N Z Med J 1987;100:102–5.
522. Sparrow MJ. Pregnancies in reliable pill takers. N Z Med J
1989;102:575–7.
523. Sparrow MJ. Pill method failures in women seeking abortion—fourteen
years experience. N Z Med J 1998;111:386–8.
524. van Dijke CP, Weber JC. Interaction between oral contraceptives and
griseofulvin. Br Med J (Clin Res Ed) 1984;288:1125–6.
525. Wermeling DP, Chandler MH, Sides GD, Collins D, Muse KN.
Dirithromycin increases ethinyl estradiol clearance without allowing
ovulation. Obstet Gynecol 1995;86:78–84.
526. Young LK, Farquhar CM, McCowan LM, Roberts HE, Taylor J. The
contraceptive practices of women seeking termination of pregnancy in
an Auckland clinic. N Z Med J 1994;107:189–92.
527. Abrams LS, Skee D, Natarajan J, Wong FA. Pharmocokinetic overview
of Ortho Evra/Evra. Fertil Steril 2002;77:s3–s12.
528. Dogterom P, van den Heuvel MW, Thomsen T. Absence of pharmacokinetic
interactions of the combined contraceptive vaginal ring
NuvaRing with oral amoxicillin or doxycycline in two randomized
trials. Clin Pharmacokinet 2005;44:429–38.
529. Devenport MH, Crook D, Wynn V, Lees LJ. Metabolic effects of
low-dose fluconazole in healthy female users and non-users of oral
contraceptives. Br J Clin Pharmacol 1989;27:851–9.
530. Hilbert J, Messig M, Kuye O. Evaluation of interaction between fluconazole
and an oral contraceptive in healthy women. Obstet Gynecol
2001;98:218–23.
531. Kovacs I, Somos P, Hamori M. Examination of the potential interaction
between ketoconazole (Nizoral) and oral contraceptives with special
regard to products of low hormone content (Rigevidon, anteovin).
Ther Hung 1986;34:167–70.
532. Lunell NO, Pschera H, Zador G, Carlstrom K. Evaluation of the
possible interaction of the antifungal triazole SCH 39304 with oral
contraceptives in normal health women. Gynecol Obstet Invest
1991;32:91–7.
533. McDaniel PA, Cladroney RD. Oral contraceptives and griseofulvin
interactions. Drug Intell Clin Pharm 1986;20:384.
534. Meyboom RH, van Puijenbroek EP, Vinks MH, Lastdrager CJ.
Disturbance of withdrawal bleeding during concomitant use of itraconazole
and oral contraceptives. N Z Med J 1997;110:300.
535. Rieth H, Sauerbrey N. Interaction studies with fluconazole, a new
tirazole antifungal drug [in German]. Wien Med Wochenschr
1989;139:370–4.
536. Sinofsky FE, Pasquale SA. The effect of fluconazole on circulating
ethinyl estradiol levels in women taking oral contraceptives. Am J
Obstet Gynecol 1998;178:300–4.
537. van Puijenbroek EP, Feenstra J, Meyboom RH. Pill cycle disturbance
in simultaneous use of itraconazole and oral contraceptives [in Dutch].
Ned Tijedschr Geneeskd 1998;142:146–9.
538. van Puijenbroek EP, Egberts AC, Meyboom RH, Leufkens HG.
Signalling possible drug-drug interactions in a spontaneous reporting
system: delay of withdrawal bleeding during concomitant
use of oral contraceptives and itraconazole. Br J Clin Pharmacol
1999;47:689–93.
539. Verhoeven CH, van den Heuvel MW, Mulders TM, Dieben TO. The
contraceptive vaginal ring, NuvaRing, and antimycotic co-medication.
Contraception 2004;69:129–32.
540. Back DJ, Breckenridge AM, Grimmer SF, Orme ML, Purba HS.
Pharmacokinetics of oral contraceptive steroids following the administration
of the antimalarial drugs primaquine and chloroquine.
Contraception 1984;30:289–95.
541. Croft AM, Herxheimer A. Adverse effects of the antimalaria drug,
mefloquine: due to primary liver damage with secondary thyroid
involvement? BMC Public Health 2002;2:6.
542. Karbwang J, Looareesuwan S, Back DJ, Migasana S, Bunnag D. Effect
of oral contraceptive steroids on the clinical course of malaria infection
and on the pharmacokinetics of mefloquine in Thai women. Bull World
Health Organ 1988;66:763–7.
543. McGready R, Stepniewska K, Seaton E, et al. Pregnancy and use of oral
contaceptives reduces the biotransformation of proguanil to cycloguanil.
Eur J Clin Pharmacol 2003;59:553–7.
544. Wanwimolruk S, Kaewvichit S, Tanthayaphinant O, Suwannarach
C, Oranratnachai A. Lack of effect of oral contraceptive use on the
pharmacokinetics of quinine. Br J Clin Pharmacol 1991;31:179–81.
545. Back DJ, Breckenridge AM, Crawford FE, et al. The effect of rifampicin
on norethisterone pharmacokinetics. Eur J Clin Pharmacol
1979;15:193–7.
546. Back DJ, Breckenridge AM, Crawford FE, et al. The effect of rifampicin
on the pharmacokinetics of ethynylestradiol in women. Contraception
1980;21:135–43.
547. Barditch-Crovo P, Trapnell CB, Ette E, et al. The effects of rifampicin
and rifabutin on the pharmacokinetics and pharmacodynamics of a combination
oral contraceptive. Clin Pharmacol Ther 1999;65:428–38.
548. Bolt HM, Bolt M, Kappus H. Interaction of rifampicin treatment with
pharmacokinetics and metabolism of ethinyloestradiol in man. Acta
Endocrinol (Copenh) 1977;85:189–97.
549. Gupta KC, Ali MY. Failure of oral contraceptive with rifampicin. Med
J Zambia 1981;15:23.
550. Hirsch A. Sleeping pills [letter] [in French]. Nouv Presse Med
1973;2:2957.